MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

516047

Report Date :

27.06.2018

 

IDENTIFICATION DETAILS

 

Name :

EMS SA

 

 

Registered Office :

Rodovia Jornalista Francisco Aguirre Proença, S/Nº KM 8 Blocos I, II E V - Chácara Assay

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2017

 

 

Date of Incorporation :

09.01.1964

 

 

Legal Form :

Privately Held Corporation

 

 

Line of Business :

Manufacture of pharmaceuticals

 

 

No. of Employees :

4866

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

--

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(31.12.2017)

Current Rating

(01.04.2018)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


 

BRAZIL - ECONOMIC OVERVIEW

 

Brazil is the eighth-largest economy in the world, but is recovering from a recession in 2015 and 2016 that ranks as the worst in the country’s history. In 2017, Brazil`s GDP grew 1%, inflation fell to historic lows of 2.9%, and the Central Bank lowered benchmark interest rates from 13,75% in 2016 to 7% in 2017.

 

Economic reforms, proposed in 2016, aim to slow the growth of government spending and reduce barriers to foreign investment. Government spending growth pushed public debt to 73.7% of GDP at the end of 2017, up from over 50% in 2012. Policies to strengthen Brazil’s workforce and industrial sector, such as local content requirements, have boosted employment at the expense of investment.

 

Former President Dilma ROUSSEFF was impeached and convicted in August 2016 for moving funds among government budgets; the economy has also been affected by multiple corruption scandals involving private companies and government officials. Sanctions against the firms involved — some of the largest in Brazil — have limited their business opportunities, producing a ripple effect on associated businesses and contractors but creating opportunities for foreign companies to step into what had been a closed market. The following TEMER administration implemented a series of fiscal and structural reforms to restore credibility to government finances. Congress approved legislation in December 2016 to cap public spending, and in mid-2017 passed labor reforms. The government also boosted infrastructure projects, such as oil and natural gas auctions, in part to raise revenues.

 

Brazil is a member of the Common Market of the South (Mercosur), a trade bloc that includes Argentina, Paraguay and Uruguay - Venezuela’s membership in the organization was suspended In August 2017. After the Asian and Russian financial crises, Mercosur adopted a protectionist stance to guard against exposure to volatile foreign markets and it currently is negotiating Free Trade Agreements with the European Union and Canada.

 

Source : CIA

 


COMPANY NAME

 

EMS S/A

 

 

ADDRESSES

 

MAIN ADDRESS:

RODOVIA JORNALISTA FRANCISCO AGUIRRE PROENÇA, S/Nº KM 8 BLOCOS I, II E V - CHÁCARA ASSAY

ZIP CODE/CITY:

13.186-901 - HORTOLÂNDIA/SP

 

 

PHONE:

19 3887-9802

E-MAIL:

wesley.carvalho@csintegrado.com.br

WEB SITE:

www.ems.com.br

 

INQUIRY DETAILS:

 

GIVEN NAME

Rod Jornalista Francisco Aguirre Proenca Km 08 S/N Hortolandia SP 13186-901

CORRECT NAME

THE CORRECT NAME IS STATED AT THE CAPTION.

 

GIVEN CNPJ

57.507.378/003-65

CORRECT CNPJ

THE CORRECT NUMBER IS STATED BELOW.

 

 

 

BRANCHES:

 

 

 

ADDRESS:

AVENIDA A, 27 A, CJ MARCOS FREIRE II - TAICOCA

ZIP CODE/CITY:

49160-000 NOSSA SENHORA DO SOCORRO/SE

CNPJ:

57.507.378/0005-27

 

 

ADDRESS:

RUA MONSENHOR OTÁVIO DE CASTRO, 167 - VILA UNIÃO

ZIP CODE/CITY:

60410-691 FORTALEZA/CE

CNPJ:

57.507.378/0007-99

 

 

ADDRESS:

RUA 1.126, QUADRA 230, LOTE 2, CASAS 1 E 2, SETOR MARISTA

ZIP CODE/CITY:

74175-050 GOIÂNIA/GO

CNPJ:

57.507.378/0008-70

 

 

ADDRESS:

268 MUNOZ RIVERA AVE, WESTERNBANK WORLD PLAZA, SUÍTE,808 SAN JUAN

ZIP CODE/CITY:

PORTO RICO, PR 00918

 

 

ADDRESS:

RUA COMENDADOR CARLO MARIO GARDANO, 450 - VILA SANTA RITA DE CÁSSIA

ZIP CODE/CITY:

09720-470 SÃO BERNARDO DO CAMPO/SP

CNPJ:

57.507.378/0001-01

 

 

ADDRESS:

AVENIDA TORQUATO TAPAJOS, 17 SALA B - TARUMA

ZIP CODE/CITY:

69041-025 MANAUS/AM

 

 

ADDRESS:

AVENIDA TORQUATO TAPAJÓS, 17703 SALA C, ÁREA DE TRANSIÇÃO

ZIP CODE/CITY:

69041-025 MANAUS/AM

 

 

ADDRESS:

LOT POLO DE DESENVOLVIMENTO JUSCELINO KUBITSCHEK TRECH, S/N TRECHO 05, CONJ 06 LOTE 06 07 08 E 09 - SANTA MARIA

ZIP CODE/CITY:

72549-550 BRASILIA/DF

CNPJ:

57.507.378/0006-08

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACTURE OF PHARMACEUTICALS.

 

LEGAL FORM:

PRIVATELY HELD CORPORATION

 

 

INCORPORATION DATE:

09/01/1964

REGISTER DATE:

09/01/1964

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

57.507.378/0003-65

STATE REGISTER:

748.002.161.113

 

 

SHARE CAPITAL:

R$ 221.716.502,41

LAST REGISTER OF CAPITAL:

26/11/2012

 

BOARD OF DIRECTORS:

 

 

 

LUIZ CARLOS BORGONOVI

PRESIDENT DIRECTOR

ISRAEL DOMINGOS BACAS

DIRECTOR

JULIO CESAR BORGES

DIRECTOR

DANIEL EDWARDO SALAZAR

DIRECTOR

CLAUDIA ELISA DE PINHO

DIRECTOR

TOBIAS JOHANNES HENZEL

DIRECTOR

 

 

AUTHORIZED USE OF SIGNATURE

 

THE DIRECTORS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

NC PARTICIPACOES S/A

99%

GERMED FARMACÊUTICA LDA.

1%

 

AFFILIATES / SUBSIDIARIES:

 

 

 

A SCAN THROUGH OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR DIRECTORS HAS/HAVE THE FOLLOWING UNCONFIRMED HOLDINGS:

 

 

NC INVESTIMENTOS LTDA

 

BOURGOGNE ADMINISTRADORA DE BENS E PARTICIPAÇÕES LTDA

 

B CONSULTORIA EMPRESARIAL LTDA

 

EMS SIGMA PHARMA LTDA

99,00%

LEGRAND PHARMA INDUSTRIA FARMACÊUTICA LTDA

99,00%

LUXBIOTECH FARMACÊUTICA LTDA

99,31%

AUVERGNE ADMINISTRADORA DE BENS E PARTICIPAÇÕES LTDA

 

GRONIN PHARMA PARTICIPAÇÕES S/A

 

CLINTECH PARTICIPAÇÕES S/A

 

LCB CONSULTORIA EMPRESARIAL LTDA

 

CPM CONCESSIONÁRIA PAULISTA DE MEDICAMENTOS S/A

99,38%

MONTERESEARCH SRL (ITALY)

100,00%

RIO BIO PHARMACEUTICALS, LLC (UNITED STATES)

100,00%

LUCERNE PROMOCAO E PUBLICIDADE LTDA

 

AGROPASTORIL VITORIA LTDA

 

 

 

COMPANY'S BACKGROUND

 

THE HISTORY OF EMS SIGMA PHARMA GROUP STARTS IN 1964, IN THE CITY OF SANTO ANDRÉ, WHEN THE PHARMACY CALLED SANTA CATARINA WAS ESTABLISHED BY EMILIANO SANCHEZ. AFTER 13 YEARS OF HARD WORK, DEDICATION AND GROWING, THE SMALL PHARMACY WAS TRANSFORMED INTO THE LABORATORY CALLED EMS.

 

DURING THE FOLLOWING YEARS, AS PART OF THEIR EXPANSION STRATEGY, THE LABORATORIES LEGRAND AND NOVAQUÍMICA WERE PURCHASED, FURTHER TO THE EXPANSION OF THE PRODUCTS LINE AND THE SEGMENT OF ACTIVITY, COMPLETING THE COMPANY'S PORTFOLIO.

 

CURRENTLY, THE GROUP IS COMPOSED BY THE COMPANIES EMS, LEGRAND, SIGMA PHARMA AND NATURE'S, ACTING IN THE PHARMACEUTICAL, GENERIC, CONSUME, HOSPITAL AND PERSONAL HYGIENE SEGMENTS. THE GROUP HAS AS HIGHLIGHT IT PIONEER CONDITION WITH GENERIC MEDICATIONS, BEING THE FIRST COMPANY TO RECEIVE THE APPROVAL OF ANVISA TO MANUFACTURE AND MERCHANDISE THE MEDICATION CALLED CYCLOSPORINE, WHICH IS DESTINED TO AVOID THE REJECTION OF TRANSPLANT ORGANS.

 

ONE OF THE LARGEST COMPANIES WITH ASSETS CAPITAL BEING 100% NATIONAL, IN 39 YEARS OF ACTIVITY IN THE BRAZILIAN MARKET, REACHED THE 11TH PLACE IN THE PHARMACEUTICAL INDUSTRIES RANKING (SOURCE: IMS HEALTH, 2002).

 

THE GROUP HAS TWO PRODUCTION UNITS LOCATED IN SÃO BERNARDO DO CAMPO AND HORTOLÂNDIA, SP, BEING THE LAST ONE THE MOST UPDATED COMPANY OF LATIN AMERICA, STRUCTURED ACCORDING TO THE STANDARDS ESTABLISHED BY THE FDA (FOOD AND DRUG ADMINISTRATION).

 

WITH 2,800 EMPLOYEES DISTRIBUTED IN THE ADMINISTRATION, COMMERCIAL AND INDUSTRIAL AREAS, THE EMS SIGMA PHARMA GROUP MANUFACTURES AND MERCHANDISE FOR ALL THE COUNTRY MORE THAN 350 PRODUCTS, ALL OF THEM MANUFACTURED UNDER THE MOST STRICT QUALITY STANDARDS, CONTRIBUTING IN THIS WAY TO IMPROVE THE HEALTH AND QUALITY OF LIFE OF ALL BRAZILIANS

 

ON DECEMBER 17, 2002 THE SUBJECT COMPANY CHANGED ITS CORPORATE NAME FROM EMS INDÚSTRIA FARMACÊUTICA LTDA TO THE CURRENT ONE.

 

SHAREHOLDERS AND DIRECTORS:

 

NC PARTICIPAÇÕES S.A., HEADQUARTERED AT HORTOLÂNDIA, ESTADO DE SÃO PAULO, À RODOVIA JORNALISTA FRANCISCO AGUIRRE PROENÇA KM 08, SALA 03, CHÁCARA ASSAY, GEP 13186-901, CHÁCARA ASSAY, REGISTRATION # CNPJ SOB O Nº 05.491.842/0001-07, AND NIRE 35.3.0019410-1, IT REPRESENTATIVE FOR YOUR PRESIDENT DIRECTOR, SR. LUIZ CARLOS BORGONOVI, BRAZILIAN, HOLDER OF DOCUMENTS RG Nº 4.801.969-0 (SSP/SP), AND CPF SOB O Nº 504.486.688-15, AND FOR YOUR VICE PRESIDENT DIRECTOR, SR. ISRAEL DOMINGOS BACAS, BRAZILIAN, HOLDER OF DOCUMENTS RG Nº 14.040.628-1 (SSP/SP), INSCRITO NO CPF SOB O Nº 048.348.648-55, WITH ADDRESS AT RODOVIA JORNALISTA FRANCISCO AGUIRRE PROENÇA KM 08, CHÁCARA ASSAY, CEP 13186-901; AND

 

GERMED FARMACÊUTICA LDA., HEADQUARTERED AT À RUA ALTO DE MONTIJO, 13, 1º DT, EDIFÍCIO MONSANTO, 2790-012, PORTELA DE CARNAXIDE, PORTUGAL, REGISTRATION # C.R.C. DE LISBOA NUMBER 13.438, IT IS REPRESENTATIVE FOR YOUR  ATTONERY MR. AUGUSTO VISEU FERNANDES, PORTUGUÊS, HOLDER OF DOCUMENTS RNE N-W137047 -S, INSCRITO NO CPF SOB O N2 114.323.658-00, WITH ADDRESS AT AVENIDA FLAMENGO N2 156, JARDIM PANORAMA, CEP 13280-000. VINHEDO/SP;

 

LUIZ CARLOS BORGONOVI, BRAZILIAN, ENTREPRENEUR, HOLDER OF DOCUMENTS CPF: 504.486.688-15, RG/RNE: 4801969 - SP, WITH ADDRESS AT RODOVIA JORNALISTA FRANCISCO AGUIRRE PRO, S/N, KM 08, CHACARA ASSAY, HORTOLANDIA - SP, ZIP CODE 13186-901

 

ISRAEL DOMINGOS BACAS, BRAZILIAN, ENTREPRENEUR, HOLDER OF DOCUMENTS CPF: 048.348.648-55, RG/RNE: 140406281 - SP, WITH ADDRESS AT RODOVIA JORNALISTA FRANCISCO AGUIRRE PRO, S/N, KM 08, CHACARA ASSAY, HORTOLANDIA - SP, ZIP CODE 13186-901

 

JULIO CESAR BORGES, BRAZILIAN, ENTREPRENEUR, HOLDER OF DOCUMENTS CPF: 871.599.108-34, RG/RNE: 77078123 - SP, WITH ADDRESS AT RODOVIA JORNALISTA FRANCISCO AGUIRRE PRO, S/N, KM 08, CHACARA ASSAY, HORTOLANDIA - SP, ZIP CODE 13186-901

 

DANIEL EDWARDO SALAZAR, BRAZILIAN, ENTREPRENEUR, HOLDER OF DOCUMENTS CPF: 237.883.768-21, RG/RNE: RNEG198818G - DF, WITH ADDRESS AT RODOVIA JORNALISTA FRANCISCO AGUIRRE PRO, S/N, KM 08, CHACARA ASSAY, HORTOLANDIA - SP, ZIP CODE 13186-901

 

CLAUDIA ELISA DE PINHO SOARES, BRAZILIAN, ENTREPRENEUR, HOLDER OF DOCUMENTS CPF: 005.639.287-78, RG/RNE: 73761470 - RJ, WITH ADDRESS AT RODOVIA JORNALISTA FRANCISCO AGUIRRE PRO, S/N, KM 08, CHACARA ASSAY, HORTOLANDIA - SP, ZIP CODE 13186-901

 

TOBIAS JOHANNES HENZEL, GERMAN, ENTREPRENEUR, HOLDER OF DOCUMENTS CPF: 230.126.158-14, RG/RNE: RNEV368787X - DF, WITH ADDRESS AT RODOVIA JORNALISTA FRANCISCO AGUIRRE PRO, S/N, KM 08, CHACARA ASSAY, HORTOLANDIA - SP, ZIP CODE 13186-901

 

FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN.

 

 

PUBLIC RECORDS INFORMATION

 

PROTESTS:

 

8  PROTESTS,TOTAL AMOUNT R$ 73.804,73

    DATE OF FIRST PROTEST: APRIL/2015  R$ 824,39

    DATE OF HIGHEST PROTEST: APRIL/2015  R$ 4.003,31

 

 

DETAILS OF LATEST PROTESTS:

 

NOTARY OFFICE:

DATE:

VALUE:

1º CARTORIO DE SP-SUMARÉ

14/04/2015

R$ 824,39

1º CARTORIO DE DF-GAMA

13/06/2018

R$ 414,97

2º CARTORIO DE PE-RECIFE

09/12/2015

R$ 6.000,00

1º CARTORIO DE SP-SUMARÉ

14/04/2015

R$ 2.444,68

1º CARTORIO DE SP-SUMARÉ

23/05/2018

R$ 7.770,00

 

LAWSUITS:

 

 

 

DATE:

COURT OF LAW:

 

2

MUNICIPAL LAWSUITS

14/11/14

VARA DE SP-CAMPINAS

3

EXECUTIVE LAWSUITS

25/03/16

8ª VARA DE SP-CAMPINAS

1

MONITORY SUIT

15/08/16

1ª VARA DE SP-CAMPINAS

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2017, 31/12/2016 AND 31/12/2015.

(FIGURES ARE IN THOUSANDS OF REAIS).

 

ASSETS

 

 

 

CURRENT:

31/12/2017

31/12/2016

31/12/2015

 

 

 

 

CASH AND BANKS

18.068

12.229

21.188

CLIENTS

455.895

487.530

454.097

INVENTORY

381.596

430.914

340.915

OTHER CREDITS

69.008

56.659

87.045

INTERCOMPANY CREDITS

102.780

42.916

125.599

RECOVERABLE TAXES

78.680

36.582

9.147

DIVIDENDS RECEIVABLES

29.968

29.968

59.948

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

1.135.995

1.096.798

1.097.939

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

JUDICIAL DEPOSITS

37.409

20.523

27.337

DEFERRED TAXES

85.158

55.952

46.176

INTERCOMPANY CREDITS

 

118.089

19.888

RECOVERABLE TAXES

6.703

6.703

6.703

INVESTMENTS

 

3.081

3.098

OTHER CREDITS

4.996

5.072

4.996

INVESTMENTS

 

2.884

2.086

INVESTMENTS

3.372

 

 

GRANTED LOANS

269.961

 

 

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

407.599

212.304

110.284

 

FIXED ASSETS:

 

 

 

 

 

 

 

INVESTMENTS

362.018

262.577

159.548

FIXED ASSETS

413.684

12.544

3.629

INTANGIBLE

14.616

409.376

395.650

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

790.318

684.497

558.827

 

================

================

================

TOTAL ASSETS

2.333.912

1.993.599

1.767.050

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2017

31/12/2016

31/12/2015

 

 

 

 

LOANS AND FINANCING

61.943

48.897

48.381

SUPPLIERS

132.756

188.129

195.193

INTERCOMPANY DEBTS

748.064

339.583

278.585

ACCOUNTS PAYABLE

110.100

110.834

61.769

INSTALLMENTS TAXES PAYABLE

7.927

7.770

7.244

INCOME TAX/SOCIAL CONTRIBUTION

 

8.610

5.579

TAX LIABILITIES

24.542

28.367

28.520

SOCIAL / LABOR OBLIGATIONS

57.620

45.671

39.639

DIVIDENDS

91.723

92.986

149.629

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

1.234.675

870.847

814.539

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

83.975

111.431

103.406

INSTALLMENTS TAXES PAYABLE

21.107

23.295

23.175

PROVISION FOR CONTINGENCIES

114.975

93.325

46.089

DEFERRED REVENUE

19.032

19.032

19.032

RELATED COMPANIES

 

 

31.208

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

239.089

247.083

222.910

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

221.708

221.708

221.708

CAPITAL RESERVES

164.019

164.019

164.019

PROFIT RESERVES

306.637

320.395

177.330

RESERVES/TAX INCENTIVES

125.206

125.206

122.203

LEGAL RESERVES

44.341

44.341

44.341

OTHER COMPREHENSIVE INCOME

-1.763

 

 

 

----------------

----------------

----------------

TOTAL NET EQUITY

860.148

875.669

729.601

 

================

================

================

TOTAL LIABILITIES

2.333.912

1.993.599

1.767.050

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2017, 31/12/2016 AND 31/12/2015.

(FIGURES ARE IN THOUSANDS OF REAIS).

 

 

31/12/2017

31/12/2016

31/12/2015

 

 

 

 

NET SALES

3.290.563

2.698.680

2.112.290

(-) COST OF SOLD GOODS

1.782.656

1.419.880

1.087.476

 

----------------

----------------

----------------

GROSS PROFIT

1.507.907

1.278.800

1.024.814

OPERATING REVENUE (EXPENSE)

-1.075.766

-841.146

-768.871

FINANCIAL REVENUE(EXPENSE)

-9.489

-28.897

-53.017

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

422.652

408.757

202.926

CONTRIBUTION/INCOME TAX

-116.382

-100.477

-36.807

 

----------------

----------------

----------------

NET PROFIT (LOSS)

306.270

308.280

166.119

 

RATIOS:

31/12/2017

31/12/2016

31/12/2015

 

QUICK RATIO

,61

 

,76

 

,93

 

CURRENT RATIO

,92

 

1,26

 

1,35

 

ACCOUNTS RECEIVABLE TURNOVER

7,22

TIMES

5,54

TIMES

4,65

TIMES

DAYS' SALES IN RECEIVABLES

49,88

DAYS

65,04

DAYS

77,39

DAYS

INVENTORY TURNOVER

4,67

TIMES

3,30

TIMES

3,19

TIMES

ACCOUNTS PAYABLE PERIOD

26,81

DAYS

47,70

DAYS

64,62

DAYS

RETURN ON ASSETS

1,41

TIMES

1,35

TIMES

1,20

TIMES

SALES TURNOVER ON NET EQUITY

3,83

TIMES

3,08

TIMES

2,90

TIMES

NET WORTH TIE-UP

,48

 

,01

 

,01

 

INDEBTEDNESS

1,71

 

1,28

 

1,42

 

EQUITY RATIO

36,85

%

43,92

%

41,29

%

WORKING CAPITAL RATIO

-7,99

%

25,95

%

34,79

%

GENERAL SOLVENCY

1,58

 

1,78

 

1,70

 

RETURN ON NET EQUITY

35,61

%

35,21

%

22,77

%

RETURN ON SALES (PROFIT MARGIN)

9,31

%

11,42

%

7,86

%

GROSS PROFIT MARGIN

45,83

%

47,39

%

48,52

%

OPERATIONAL RESULT

12,84

%

15,15

%

9,61

%

SALES TURNOVER ON LIABILITIES

2,67

TIMES

3,10

TIMES

2,59

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. IT HAS LOW LIQUIDITY AND HIGH LEVEL OF INDEBTEDNESS. ON THE OTHER HAND, IT IS NOTED GROWING SALES AND GOOD PROFITABILITY.

 

IT IS WORTH TO COMMENT THAT THE SUBJECT HAS A HIGH FINANCIAL STRENGTH AND SO FAR IT OPERATES NORMALLY BEING NOT LIKELY TO FACE FINANCIAL PROBLEMS.

 

 

REAL ESTATE:

 

NOT AVAILABLE

 

 

VEHICLES:

 

NOT AVAILABLE

 

 

MACHINES:

 

NOT AVAILABLE

 

 

INSURANCE:

 

NOT AVAILABLE.

 

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

CITY:

ITAÚ UNIBANCO S/A

0009  /  19 3735-9709

CAMPINAS/SP

BANCO SANTANDER (BRASIL) S/A

 

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

THE SUBJECT IS ENGAGED IN THE MANUFACTURE AND TRADE OF PHARMACEUTICAL PRODUCTS.

 

NATIONAL INDUSTRY CLASSIFICATION CODE(S) (CNAE):

21.21-1-01 - MANUFACTURE OF ALLOPATHIC MEDICAMENTS FOR HUMAN USE;

21.21-1-03 - MANUFACTURE OF HERB MEDICAMENTS FOR HUMAN USE;

82.11-3-00 - COMBINED OFFICE ADMINISTRATIVE SERVICE ACTIVITIES

 

IMPORT AND EXPORT:

 

IMPORTS FROM:

 

ITALY, GERMANY, FRANCE, CANADA, INDIA AND SWEDEN.

 

EXPORTS TO:

 

PORTUGAL, GERMANY AND ENGLAND.

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

CITY:

PHONE:

DIST.DE DROGAS NORFARMA LTDA

ARAÇATUBA/SP

18  623-3645

DISTR. FARMACÊUTICA PANARELLO LTDA

GOIÂNIA/GO

62 3285-6611

DISTR. MEDICAMENTOS SANTA CRUZ LTDA

CURITIBA/PR

41 3316-2209

DISTR.DROGAS CENTRO OESTE LTDA.

CAMPO GRANDE/MS

67  382-6188

ITA REPRES. PRODS. FARMACÊUTICOS

SANTA BÁRBARA D´OESTE/SP

19 3459-4000

JAMYR VASCONCELOS S/A

RIO DE JANEIRO/RJ

21 2472-2828

PERFORMA DISTR. PRODS. FARMACÊUTICOS LTDA

RIACHO DAS PEDRAS/MG

21 3450-1416

UNIFARMA DISTRIBUISDORA FARMACEUTICA LTDA

IMPERATRIZ/MA

98 3525-3486

 

STAFF:

 

THE COMPANY HAS: 4866 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS AN OLD-ESTABLISHED COMPANY, OPERATING SINCE 1964 WITH A LEADING MARKET POSITION. IT HAS A HIGH AND GROWING SCALE OF ACTIVITIES AND AN EXCELLENT TRADE REPUTATION.

 

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

THE LAWSUITS REPORTED ARE NOT RELATED WITH TRADE DEBTS. THEY ARE RELATED TO TAX DEBTS THAT FOR ANY REASON THE COMPANY HAS NOT YET PAID. NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUITS DO NOT AFFECT THE COMPANY'S TRADE REPUTATION.

 

OUR INVESTIGATION THROUGH THE PUBLIC RECORDS SHOWED SOME DETRIMENTAL FILES REGISTERED AGAINST THE SUBJECT BUT DUE TO THE SUBJECT'S HIGH FINANCIAL STRENGTH AND HIGH SCALE OF OPERATIONS THE DETRIMENTAL FILES DO NOT AFFECT ITS TRADE REPUTATION.

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

CITY:

PHONE:

ALLPLAS INDÚSTRIA.COM.PLÁSTICOS LTDA

CARAPICUIBA/SP

 

BAFEMA S/A INDÚSTRIA E COMÉRCI0

SÃO PAULO/SP

 

BOAINAIN DIOSTR. DE ALCOOL LTDA

OSASCO/SP

 

CIA. UNIÃO REFINADORES AÇÚCAR E CAFÉ

SÃO PAULO/SP

 

COLORCON DO BRASIL LTDA

COTIA/SP

 

ESQYEMA IND.COM.EMBALAGENS LTDA

OSASCO/SP

 

FENIL QUÍMICA LTDA

SÃO PAULO/SP

 

HENRIFARMA PRODS.QUI.FARM. LTDA

SÃO PAULO/SP

 

M. CASSAB COMERCIO E INDUSTRIA LTDA

SÃO PAULO/SP

 

PRODUTOS ROCHE QUÍM. FARMACÊUTICA S/A

SÃO PAULO/SP

 

VEDAT TAMPAS HERMETICAS LTDA

EMBU/SP

 

VITROSUL IND.COM.VIDORS LTDA

EMBÚ/SP

 

VULCAN MARTERIAL PLÁSTICO S/A

RIO DE JANEIRO/RJ

 

WHEATON DO BRASIL S/A

SÃO BERNARDO CAMPO/SP

 

 

PAYMENT HISTORY:

 

37 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 8.912.256,00

 

AMOUNT OF INVOICES PAID: 289

TOTAL OF PROMPT PAYMENTS: 97,8%

TOTAL OF DELAYED PAYMENTS: 2,2%

 

HIGHEST INVOICE: R$ 323.522,00

HIGHEST CREDIT: R$ 555.599,00

 

OUTSTANDING INVOICES DUE WITHIN THE NEXT 60 DAYS:

 

---------------------------

SUPPLIERS:

INVOICES:

TOTAL AMOUNT:

DUE WITHIN 30 DAYS

4

5

R$ 83.654,45

DUE WITHIN 60 DAYS

1

4

R$ 661,16

DUE WITHIN 90 DAYS

1

1

R$ 42.500,00

ALL

5

10

R$ 126.815,61

 

 

FINAL OPINION

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR SEVERAL YEARS. UP TO DATE IT HAS CLEAR TRADE HISTORY AND GOOD PAYMENT PERFORMANCE.

 

BASED ON THE OVERALL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S SIZE AND FINANCIAL STRENGTH.

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

INR 68.16

UK Pound

1

INR 90.47

Euro

1

INR 79.74

BRL

1

INR 18.05

 

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

VAR

 

 

Report Prepared by :

SUJ

                                                


 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.